相关实验视频

Updated: Feb 1, 2026

Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines

Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines

Published on: July 19, 2019

综合性蛋白质基因组学绘制了胃癌多因素病因,进展和治疗脆弱性的地图

Ya-Hsuan Chang^1,2,3, Tzu-Chan Hong^4,5,6, Kuen-Tyng Lin⁷

¹Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.

|January 30, 2026

概括

这项研究揭示了与环境暴露和微生物群相关的新胃癌亚型,为个性化治疗和预防策略提供了见解. 它确定了影响患者结果的特定微生物和致癌特征.

科学领域:

在瘤学瘤学.
微生物组研究微生物组研究
蛋白质基因组学是什么

背景情况:

胃癌发病率在东亚很高,这是由Helicobacter pylori (HP) 以外的复杂相互作用驱动的.
在胃癌中,环境致癌物,微生物变化和宿主反应之间的分子联系尚未完全理解.

研究的目的:

确定胃癌的多因素原因和临床相关的亚型/生物标志物.
使用集成的蛋白质基因组,微生物和环境暴露概况.

主要方法:

从154名以前没有接受过治疗的患者的瘤,邻近的粘膜和血液样本创建了一个多组图谱.
综合整体外因子测序,RNA-seq,蛋白质组,蛋白质组,致癌特征,HP状态,微生物组合和解剖绘制.
在一个独立的队列中对致癌效应进行了基于细胞的测定,并评估了微生物亚型.

主要成果:

鉴定出一种多环芳的碳化合物特征 (dibenz[a,h]acridine) 是一种高风险暴露物,促进了侵袭和免疫抑制.
定义了三种胃癌发病生态:HP驱动的炎症性,非HP微生物组丰富的免疫沉默性和没有HP的微生物枯竭.
在HP阴性瘤中发现了一种Streptococcus丰富的亚型,与紧密结节中断相关,并确定了可操作的治疗漏洞,如CLDN18.2-高表皮稳定亚型.

结论:

开发了胃癌的蛋白质基因组框架.
确立的暴露信息和微生物组信息的亚型,用于患者分层.
为改善预防和治疗点的识别提供了分子基础.

关键词:

胃癌胃癌胃癌胃癌微生物组微生物组分子致癌的产生.分子遗传学分子遗传学蛋白质组学蛋白质组学

更多相关视频

Elastic Staining on Paraffin-embedded Slides of pT3N0M0 Gastric Cancer Tissue

Elastic Staining on Paraffin-embedded Slides of pT3N0M0 Gastric Cancer Tissue

Published on: May 1, 2019

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Published on: June 28, 2013

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Gastric Motility

Gastric Motility

Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...

Gastric Emptying

Gastric Emptying

Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...

Gastric Phase of Digestion

Gastric Phase of Digestion

The gastric phase of digestion begins as soon as food enters the stomach. The incoming food bolus triggers neural and hormonal mechanisms, which last approximately 3 to 4 hours. During this phase, the stomach undergoes significant changes to prepare the food for further digestion and absorption.
When food enters the stomach, it stretches the stomach walls and activates stretch receptors. This triggers local reflexes of the enteric nervous system, mediated through the myenteric plexus. These...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Therapeutic Index

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...